MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02321nam a22002537a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
MED 2022 0004 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
PILC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240720153319.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
230619b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Language of cataloging |
eng |
| Transcribing agency |
FEU-NRMF MEDICAL LIBRARY |
| Description conventions |
rda |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
english |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
MED 2022 0004 |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
The Use of QRISK3 VS framingham in the estimation of cardiovascular disease risk in patients with systematic lupus erythematosus : |
| Remainder of title |
a retrospective cohort study / |
| Statement of responsibility, etc. |
Kayla Pamela B. de la Cerna. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Fairview, Quezon City: |
| Name of publisher, distributor, etc. |
Department of Internal Medicine, FEU-NRMF, |
| Date of publication, distribution, etc. |
2022. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Other physical details |
illustrations, tables; |
| Dimensions |
(in folder) |
| Accompanying material |
with flash drive (soft copy). |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes appendices and bibliographical references. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Abstract: Cardiovascular disease (CVD) is a major cause of morbidity and mortality in patients will systematic lupus enrythematosus (SLE). Studies have shown that SLE patient have a higher risk of developing cardiovascular diseases compared to the general population. Multiple prediction tools such as the Framingham Risk Score (FRS) has been used for primary prevention of CVD event. However, some studies reported that FRS has been shown to underestimate the risk in patients with SLE. In this retrospective study, we investigated and compared the use of QRISK and FRS in the estimation of cardiovascular events among patients with SLE. A total of 100 patients fulfilled the American College of Rheumatology criteria were included. At the end of the study, we report that patients with SLE had female preponderance. The traditional CVD risk factors, higher BMI and hypertension were commonly observed. The comparison of Framingham and QRISK3 in predicting risk of CVD events among SLE patients, results of the present study indicates that QRISK3 identified four times as many SLE patients with high CVD risk than Framingham. It is recommended that a multi-center study should be done to increase the sample size. Moreover, a prospective cross sectional study was also recommended to allow investigators to have a long term follow up with the CVD events. |
| 521 ## - TARGET AUDIENCE NOTE |
|---|
| Target audience note |
Research - Department of Medicine |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
de la Cerna, Kayla Pamela B., MD. |
| Relator term |
author |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Room Use |
